Vedolizumab for colitis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Also followed for narrower conditions: Colitis, Ulcerative

Why this status

  1. 29 Mar 2024: Trial registered, NCT06337695
  2. 13 Aug 2026: Trial started, NCT06337695

The trials

NCT06337695: Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer

State
Under way
Phase
Phase 2 and Phase 3
People
36 planned
Started
13 Aug 2026
Primary completion
1 Dec 2030
Arms
Vedolizumab
Results
None posted
  1. 29 Mar 2024: Trial registered
  2. 13 Aug 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as Entyvio.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.